In Vivo Cancer Characterization and Therapy Monitoring with Diffuse Optics
The next Wednesday 16th June, the conference hall of Duran i Reynals Hospital (ICO) will hold the special seminar “In Vivo Cancer Characterization and Therapy Monitoring with Diffuse Optics”, by Dr Regine Choe, Department of Physics and Astronomy, University of Pennsylvania, Philadelphia, USA.
Continue reading ‘In Vivo Cancer Characterization and Therapy Monitoring with Diffuse Optics’
A study published in the scientific journal Cell Transplantation offers new clues in order to develop therapies for transplant cartilage from pigs in humans. The study was made by researchers of Gene Therapies and Transplant group of the Bellvitge Biomedical Research Insitute (IDIBELL), Roberta Sommaggio, Rafael Máñez and Cristina Costa. Continue reading ‘IDIBELL researchers identify proteins that cause rejection in transplantation of cartilage from pigs’
Suppose you meet an old friend on the street. You chat for a while and, finally, decide to call to talk one day with more calm. He gives you his phone number, but you don’t have any paper to write it. Anyway. You are close to home and sure you will be able to remember the number until you get there and make a note on the agenda.
A group of researchers of the Bellvitge Biomedical Research Institute (IDIBELL) has shown that the valproic acid, a medicine used against epilepsy, is also effective to treat a minority neurodegenerative disease: the X-linked adrenoleukodystrophy. The result of the research has been published in the electronic edition of the American magazine Human Molecular Genetics.
During 2009, Bellvitge Biomedical Research Center (IDIBELL) has increased its scientific results. The total impact factor of the articles published by researchers at IDIBELL during 2009 is higher than 2,900 points. This data, which still must be validated by the group leaders, is 600 points higher than 2008 impact factor and doubles the impact factor of 2004. It puts IDIBELL among one of the Spanish institutes with more scientific production.
Continue reading ‘IDIBELL's impact factor doubles in five years’
Xavier Corbella faces a challenging 2010. As manager of the Bellvitge University Hospital, manager of the South Metropolitan area of the Catalan Institute of Health and Chairman of the Board of Directors of IDIBELL has many responsibilities. He is convinced that despite the crisis, Bellvitge health campus has a long way to go.
The members of the Scientific Advisory Board of IDIBELL (SAB) meets on 15, 16 and 17 February in the campus to know the Institute’s progress and evaluate various research groups.
Continue reading ‘IDIBELL Scientific Advisory Board meets 15 to 17 of february’
Mediterranean diet has significant protective effect against gastric cancer, according to a study made by the EPIC network, participated by a group of researchers from the Catalan Institute of Oncology (ICO) and the Bellvitge Biomedical Research Institute (IDIBELL), led by Genevieve Buckland and Carlos A. Gonzalez. The study has been published in the scientific journal ‘American Journal of Clinical Nutrition’.
Continue reading ‘A study demonstrates for the first time that Mediterranean diet protects against stomach cancer’
Neurosurgeons of Bellvitge University Hospital, in Barcelona (Spain), and researchers from the Institute of Biomedical Research of Bellvitge (IDIBELL) participate in an international project, called CLEAR III, which assesses the effectiveness of the administration of a thrombolytic drug called rt-PA to treat intra-ventricular cerebral haemorrhages (hemorrhagic stroke). There is no international consensus about the best treatment of these types of hemorrhagic strokes.
Continue reading ‘Bellvitge Hospital is studying a new technique to treat cerebral haemorrhages’
Image: on the left, healthy mouse cerebellum section; on the right, cerebellum section of HERC1 mutation gene mouse almost with no Purkinje cells (in brown)
The mutation of a gene that encodes a giant protein called HERC1 in mice causes progressive degeneration of neurons in the cerebellum, whose function is to fine-tune vertebrates’ gait and balance. This is the conclusion of a study coordinated by Jose Luis Rosa, researcher at the Bellvitge Biomedical Research Institute of Barcelona (IDIBELL) and the Department of Physiological Sciences II of the Bellvitge Campus of the University of Barcelona. The results have been published in the journal PLoS Genetics. This finding could be helpful in the development of new therapies for neurodegenerative diseases.
Continue reading ‘IDIBELL and UB researchers identify a gene that causes movement problems in mice’
